Lifeward files initial beneficial ownership statement for Oramed Pharmaceuticals stake

Oramed Pharmaceuticals Incorporated
Lifeward Ltd.

Oramed Pharmaceuticals Incorporated

ORMP

0.00

Lifeward Ltd.

LFWD

0.00

  • Lifeward Ltd. Form 3 filing shows Oramed Pharmaceuticals as a 10% owner, reporting event date March 25, 2026.
  • Direct holding of 1,250,363 ordinary shares.
  • Additional exposure through derivative positions tied to ordinary shares, including 1,006,113 pre-funded warrants at USD 0 exercise price.
  • Warrants for 1,296,296 ordinary shares at USD 5.4, warrants for 1,666,666 ordinary shares at USD 5.4, senior secured convertible notes convertible into 1,666,666 ordinary shares at USD 5.4.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeward Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-056839), on May 14, 2026, and is solely responsible for the information contained therein.